Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Peadiatric And Adult Study Population

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04801420
Recruitment Status : Active, not recruiting
First Posted : March 17, 2021
Last Update Posted : July 27, 2021
Information provided by (Responsible Party):
Valneva Austria GmbH

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 2023
Estimated Study Completion Date : January 2026